tiprankstipranks
Cogent data has positive read-through to Blueprint, says Barclays
PremiumThe FlyCogent data has positive read-through to Blueprint, says Barclays
2M ago
Blueprint should rally on today’s Cogent data, says Oppenheimer
Premium
The Fly
Blueprint should rally on today’s Cogent data, says Oppenheimer
2M ago
Blueprint Medicines price target lowered to $151 from $153 at Wells Fargo
Premium
The Fly
Blueprint Medicines price target lowered to $151 from $153 at Wells Fargo
2M ago
BPMC Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsBPMC Upcoming Earnings Report: What to Expect?
2M ago
Blueprint Medicines initiated with a Neutral at UBS
Premium
The Fly
Blueprint Medicines initiated with a Neutral at UBS
2M ago
Blueprint Medicines price target raised to $127 from $112 at Baird
Premium
The Fly
Blueprint Medicines price target raised to $127 from $112 at Baird
5M ago
Blueprint Medicines price target raised to $105 from $75 at Barclays
PremiumThe FlyBlueprint Medicines price target raised to $105 from $75 at Barclays
5M ago
Blueprint Medicines price target raised to $115 from $110 at Morgan Stanley
Premium
The Fly
Blueprint Medicines price target raised to $115 from $110 at Morgan Stanley
6M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100